H. Immo Lehmann

H. Immo Lehmann, MD, PhD

Languages spoken: English

  • H. Immo Lehmann, M.D., Ph.D., is a Cardiologist specializing heart rhythm disorders such as atrial fibrillation and flutter, supraventricular arrhythmias, and ventricular arrhythmias.

    A native of Northern Germany, he completed his Internal Medicine Residency at the University of Pittsburgh Medical Center (UPMC). He completed fellowships in Cardiovascular Medicine at the Massachusetts General Hospital / Harvard Medical School, Boston, MA where he was also a John S. LaDue Memorial Fellow. He subsequently completed a fellowship in Cardiovascular Electrophysiology at the University of Michigan. During his training he also gathered extensive research experience in electrophysiology, investigating innovative and cutting-edge therapeutic technologies for arrhythmia treatment at the Mayo Clinic in Rochester, MN.

    Dr. Lehmann performs a broad range of procedures including catheter ablation of atrial fibrillation and flutter, ablation of supraventricular arrhythmias as well as ablation of ventricular tachycardias and premature ventricular contractions (PVCs). He performs cutting edge therapies such as alcohol ablation of arrhythmias. He is also well versed in the implantation of cardiac devices including pacemakers and defibrillators (traditional, leadless, and extravascular). Above all, Dr. Lehmann is committed to providing outstanding and personalized comprehensive arrhythmia care. He strives to prioritize patient empowerment and engagement in care.

    A comprehensive list of Dr. Lehmann’s publications can be found at: https://pubmed.ncbi.nlm.nih.gov/?term=lehmann+hi

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Cardiovascular Disease)
    Educational Commission for Foreign Medical Graduates
    National Board of Medical Examiners

  • H. Immo Lehmann, M.D., Ph.D., is a Cardiologist specializing heart rhythm disorders such as atrial fibrillation and flutter, supraventricular arrhythmias, and ventricular arrhythmias.

    A native of Northern Germany, he completed his Internal Medicine Residency at the University of Pittsburgh Medical Center (UPMC). He completed fellowships in Cardiovascular Medicine at the Massachusetts General Hospital / Harvard Medical School, Boston, MA where he was also a John S. LaDue Memorial Fellow. He subsequently completed a fellowship in Cardiovascular Electrophysiology at the University of Michigan. During his training he also gathered extensive research experience in electrophysiology, investigating innovative and cutting-edge therapeutic technologies for arrhythmia treatment at the Mayo Clinic in Rochester, MN.

    Dr. Lehmann performs a broad range of procedures including catheter ablation of atrial fibrillation and flutter, ablation of supraventricular arrhythmias as well as ablation of ventricular tachycardias and premature ventricular contractions (PVCs). He performs cutting edge therapies such as alcohol ablation of arrhythmias. He is also well versed in the implantation of cardiac devices including pacemakers and defibrillators (traditional, leadless, and extravascular). Above all, Dr. Lehmann is committed to providing outstanding and personalized comprehensive arrhythmia care. He strives to prioritize patient empowerment and engagement in care.

    A comprehensive list of Dr. Lehmann’s publications can be found at: https://pubmed.ncbi.nlm.nih.gov/?term=lehmann+hi

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Cardiovascular Medicine
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Cardiovascular Disease)
    Educational Commission for Foreign Medical Graduates
    National Board of Medical Examiners

    Education history

    Fellowship Cardiac Electrophysiology - University of Michigan Fellow
    Cardiology - Massachusetts General Hospital Fellow
    Research Fellow Cardiology - Harvard Medical School Research Fellow
    Internal Medicine - University of Pittsburgh Medical Center Resident
    Internship Internal Medicine - University of Pittsburgh Medical Center Intern
    Translational Interventional Electrophysiology Laboratory - Mayo Clinic Postdoctoral Fellow
    Doctoral Training Cardiology / Clinical Pharmacology - Otto-von-Guericke-University Dr. med.
    Exchange medical student - Good Samaritan Hospital and University of Rennes (CHU de Rennes)
    Doctoral Training Federal Boards of Medicine - Otto-von-Guericke-University M.D.

    Selected Publications

    Journal Article

    1. Suzuki A, Lehmann HI, Konishi H, Wang S, Hohmann S, Rettman ME, Newman LK, Parker KD, Curley MG, Packer DL (2024). Potential Microemboli Formation Risk and its Management during the Heated Saline Enhanced Radiofrequency (SERF) Needle-tip Catheter Ablation. Heart Rhythm. (Read full article)
    2. Wang L, Feng J, Feng X, Meng D, Zhao X, Wang J, Yu P, Xu GE, Hu M, Wang T, Lehmann HI, Li G, Sluijter JPG, Xiao J (2023). Exercise-induced circular RNA circUtrn is required for cardiac physiological hypertrophy and prevents myocardial ischaemia-reperfusion injury. Cardiovasc Res, 119(16), 2638-2652. (Read full article)
    3. Chatterjee E, Rodosthenous RS, Kujala V, Gokulnath P, Spanos M, Lehmann HI, de Oliveira GP, Shi M, Miller-Fleming TW, Li G, Ghiran IC, Karalis K, Lindenfeld J, Mosley JD, Lau ES, Ho JE, Sheng Q, Shah R, Das S (2023). Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system. JCI Insight, 8(22). (Read full article)
    4. Ghanbari H, Whibley D, Lehmann HI, Li Z, Kratz A, Clauw DJ, Nallamothu BK (2023). Episodes of Atrial Fibrillation and Symptoms: A Temporal Analysis. Cardiovasc Digit Health J, 4(5), 143-148. (Read full article)
    5. Chen R, Yang T, Jin B, Xu W, Yan Y, Wood N, Lehmann HI, Wang S, Zhu X, Yuan W, Chen H, Liu Z, Li G, Bowen TS, Li J, Xiao J (2023). CircTmeff1 Promotes Muscle Atrophy by Interacting with TDP-43 and Encoding A Novel TMEFF1-339aa Protein. Adv Sci (Weinh), 10(17), e2206732. (Read full article)
    6. Zhao J, Yu Y, Zhu X, Xie Y, Ai S, Lehmann HI, Deng X, Hu F, Li G, Zhou Y, Xiao J (2023). Predicting risk on cardiovascular or cerebrovascular disease based on a physical activity cohort: Results from APAC study. MedComm (2020), 4(2), e220. (Read full article)
    7. Yu P, Wang J, Xu GE, Zhao X, Cui X, Feng J, Sun J, Wang T, Spanos M, Lehmann HI, Li G, Xu J, Wang L, Xiao J (2023). RNA m(6)A-Regulated circ-ZNF609 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating FTO. JACC Basic Transl Sci, 8(6), 677-698. (Read full article)
    8. Gokulnath P, Spanos M, Lehmann HI, Sheng Q, Rodosthenous R, Chaffin M, Varrias D, Chatterjee E, Hutchins E, Li G, Daaboul G, Rana F, Wang AM, Van Keuren-Jensen K, Ellinor PT, Shah R, Das S (2023). Plasma extracellular vesicle transcriptome as a dynamic liquid biopsy in acute heart failure. (Read full article)
    9. Bei Y, Chen C, Hua X, Yin M, Meng X, Huang Z, Qi W, Su Z, Liu C, Lehmann HI, Li G, Huang Y, Xiao J (2023). A modified apical resection model with high accuracy and reproducibility in neonatal mouse and rat hearts. NPJ Regen Med, 8(1), 9. (Read full article)
    10. Lehmann HI, Sharma K, Bhatia R, Mills T, Lang J, Li G, Andrews C, Cullivan J, Singh J, Mela T (2023). Real-World Disparities in Remote Follow-Up of Cardiac Implantable Electronic Devices and Impact of the COVID-19 Pandemic: A Single-Center Experience. J Am Heart Assoc, 12(3), e027500. (Read full article)
    11. Wang L, Wang J, Yu P, Feng J, Xu GE, Zhao X, Wang T, Lehmann HI, Li G, Sluijter JPG, Xiao J (2022). METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury. Nat Commun, 13(1), 6762. (Read full article)
    12. Spanos M, Shachar S, Sweeney T, Lehmann HI, Gokulnath P, Li G, Sigal GB, Nagaraj R, Bathala P, Rana F, Shah RV, Routenberg DA, Das S (2022). Elevation of neural injury markers in patients with neurologic sequelae after hospitalization for SARS-CoV-2 infection. iScience, 25(8), 104833. (Read full article)
    13. Suzuki A, Fujiwara R, Asada H, Iwasa K, Miyata T, Song WH, Higuchi K, Seo H, Sakamoto Y, Shimizu M, Soga F, Shibata H, Kozuki A, Nagoshi R, Lehmann HI, Kijima Y, Shite J (2021). Peri-Balloon Leak Flow Velocity Assessed by Intra-Cardiac Echography Predicts Pulmonary Vein Electrical Gap　- Intra-Cardiac Echography-Guided Contrast-Free Cryoballoon Ablation. Circ J, 86(2), 256-265. (Read full article)
    14. Dickow J, Wang S, Suzuki A, Imamura K, Lehmann HI, Parker KD, Newman LK, Monahan KH, Rettmann ME, Curley MG, Packer DL (2020). Real-time intracardiac echocardiography validation of saline-enhanced radiofrequency needle-tip ablation: lesion characteristics and gross pathology correlation. Europace, 23(11), 1826-1836. (Read full article)
    15. Suzuki A, Lehmann HI, Wang S, Monahan KH, Parker KD, Rettmann ME, Curley MG, Packer DL (2020). Impact of myocardial fiber orientation on lesions created by a novel heated saline-enhanced radiofrequency needle-tip catheter: An MRI lesion validation study. Heart Rhythm, 18(3), 443-452. (Read full article)
    16. Dickow J, Suzuki A, Henz BD, Madhavan M, Lehmann HI, Wang S, Parker KD, Monahan KH, Rettmann ME, Curley MG, Packer DL (2020). Characterization of Lesions Created by a Heated, Saline Irrigated Needle-Tip Catheter in the Normal and Infarcted Canine Heart. Circ Arrhythm Electrophysiol, 13(12), e009090. (Read full article)
    17. Suzuki A, Lehmann HI, Wang S, Parker KD, Rettmann ME, Monahan KH, Packer DL (2020). Biophysical properties, efficacy, and lesion characteristics of a new linear cryoablation catheter in a canine model. Heart Rhythm, 17(11), 1967-1975. (Read full article)
    18. Suzuki A, Deisher AJ, Rettmann ME, Lehmann HI, Hohmann S, Wang S, Konishi H, Kruse JJ, Cusma JT, Newman LK, Parker KD, Monahan KH, Herman MG, Packer DL (2020). Catheter-Free Arrhythmia Ablation Using Scanned Proton Beams: Electrophysiologic Outcomes, Biophysics, and Characterization of Lesion Formation in a Porcine Model. Circ Arrhythm Electrophysiol, 13(10), e008838. (Read full article)
    19. Guhl EN, Smith B, Lehmann H, Adelstein E, Bhonsale A, Kancharla K, Voigt A, Wang NC, Saba S, Jain SK (2018). Improvement in ejection fraction after cryoballoon pulmonary vein isolation for atrial fibrillation in individuals with systolic dysfunction. J Interv Card Electrophysiol, 54(3), 225-229. (Read full article)
    20. Rapp F, Simoniello P, Wiedemann J, Bahrami K, Grnebaum V, Ktitareva S, Durante M, Lugenbiel P, Thomas D, Lehmann HI, Packer DL, Graeff C, Fournier C (2019). Biological Cardiac Tissue Effects of High-Energy Heavy Ions - Investigation for Myocardial Ablation. Sci Rep, 9(1), 5000. (Read full article)
    21. Livia C, Sugrue A, Witt T, Polkinghorne MD, Maor E, Kapa S, Lehmann HI, DeSimone CV, Behfar A, Asirvatham SJ, McLeod CJ (2018). Elimination of Purkinje Fibers by Electroporation Reduces Ventricular Fibrillation Vulnerability. J Am Heart Assoc, 7(15), e009070. (Read full article)
    22. Lehmann HI, Meltendorf U, Klein HU (2018). Long-term follow-up of permanent atrial standstill in a German family with mutation in the SCN5A gene. HeartRhythm Case Rep, 4(8), 356-358. (Read full article)
    23. Prall M, Eichhorn A, Richter D, Lehmann HI, Constantinescu A, Kaderka R, Lugenbiel P, Thomas D, Bert C, Packer DL, Durante M, Graeff C (2017). Immobilization for carbon ion beam ablation of cardiac structures in a porcine model. Phys Med, 43, 134-139. (Read full article)
    24. Richter D, Lehmann HI, Eichhorn A, Constantinescu AM, Kaderka R, Prall M, Lugenbiel P, Takami M, Thomas D, Bert C, Durante M, Packer DL, Graeff C (2017). ECG-based 4D-dose reconstruction of cardiac arrhythmia ablation with carbon ion beams: application in a porcine model. Phys Med Biol, 62(17), 6869-6883. (Read full article)
    25. Lehmann HI, Deisher AJ, Takami M, Kruse JJ, Song L, Anderson SE, Cusma JT, Parker KD, Johnson SB, Asirvatham SJ, Miller RC, Herman MG, Packer DL (2016). External Arrhythmia Ablation Using Photon Beams: Ablation of the Atrioventricular Junction in an Intact Animal Model. Circ Arrhythm Electrophysiol, 10(4). (Read full article)
    26. Lehmann HI, Graeff C, Simoniello P, Constantinescu A, Takami M, Lugenbiel P, Richter D, Eichhorn A, Prall M, Kaderka R, Fiedler F, Helmbrecht S, Fournier C, Erbeldinger N, Rahm AK, Rivinius R, Thomas D, Katus HA, Johnson SB, Parker KD, Debus J, Asirvatham SJ, Bert C, Durante M, Packer DL (2016). Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams. Sci Rep, 6, 38895. (Read full article)
    27. Constantinescu A, Lehmann HI, Packer DL, Bert C, Durante M, Graeff C (2016). Treatment Planning Studies in Patient Data With Scanned Carbon Ion Beams for Catheter-Free Ablation of Atrial Fibrillation. J Cardiovasc Electrophysiol, 27(3), 335-44. (Read full article)
    28. Takami M, Lehmann HI, Parker KD, Welker KM, Johnson SB, Packer DL (2016). Effect of Left Atrial Ablation Process and Strategy on Microemboli Formation During Irrigated Radiofrequency Catheter Ablation in an In Vivo Model. Circ Arrhythm Electrophysiol, 9(1), e003226. (Read full article)
    29. Takami M, Lehmann HI, Misiri J, Parker KD, Sarmiento RI, Johnson SB, Packer DL (2015). Impact of freezing time and balloon size on the thermodynamics and isolation efficacy during pulmonary vein isolation using the second generation cryoballoon. Circ Arrhythm Electrophysiol, 8(4), 836-45. (Read full article)
    30. Lehmann HI, Richter D, Prokesch H, Graeff C, Prall M, Simoniello P, Fournier C, Bauer J, Kaderka R, Weymann A, Szab G, Sonnenberg K, Constantinescu AM, Johnson SB, Misiri J, Takami M, Miller RC, Herman MG, Asirvatham SJ, Brons S, Jkel O, Haberer T, Debus J, Durante M, Bert C, Packer DL (2015). Atrioventricular node ablation in Langendorff-perfused porcine hearts using carbon ion particle therapy: methods and an in vivo feasibility investigation for catheter-free ablation of cardiac arrhythmias. Circ Arrhythm Electrophysiol, 8(2), 429-38. (Read full article)
    31. Prall M, Lehmann HI, Prokesch H, Richter D, Graeff C, Kaderka R, Sonnenberg K, Hauswald H, Weymann A, Bauer J, Constantinescu A, Haberer T, Debus J, Szab G, Korkmaz S, Durante M, Packer DL, Bert C (2014). Treatment of arrhythmias by external charged particle beams: a Langendorff feasibility study. Biomed Tech (Berl), 60(2), 147-56. (Read full article)
    32. Rettmann ME, Holmes DR 3rd, Johnson SB, Lehmann HI, Robb RA, Packer DL (2015). Analysis of Left Atrial Respiratory and Cardiac Motion for Cardiac Ablation Therapy. Proc SPIE Int Soc Opt Eng, 9415. (Read full article)
    33. Takami M, Misiri J, Lehmann HI, Parker KD, Johnson SB, Sarmiento RI, Packer DL (2014). Spatial and time-course thermodynamics during pulmonary vein isolation using the second-generation cryoballoon in a canine in vivo model. Circ Arrhythm Electrophysiol, 8(1), 186-92. (Read full article)
    34. Lehmann HI, Wolke C, Malenke W, Rhl FW, Hammwhner M, Bukowska A, Lendeckel U, Goette A (2012). Enzymatic activity of DPIV and renin-angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD). Int J Cardiol, 168(1), 255-60. (Read full article)
    35. Lehmann HI, Goette A, Martens-Lobenhoffer J, Hammwhner M, Rhl FW, Bukowska A, Ghanem A, Klein HU, Bode-Bger SM (2011). Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction. Europace, 13(10), 1428-35. (Read full article)

    Review

    1. Jiang J, Ni L, Zhang X, Chatterjee E, Lehmann HI, Li G, Xiao J (2023). Keeping the Heart Healthy: The Role of Exercise in Cardiac Repair and Regeneration. [Review]. Antioxid Redox Signal, 39(16-18), 1088-1107. (Read full article)
    2. Qiu Y, Fernndez-Garca B, Lehmann HI, Li G, Kroemer G, Lpez-Otn C, Xiao J (2022). Exercise sustains the hallmarks of health. [Review]. J Sport Health Sci, 12(1), 8-35. (Read full article)
    3. Yang X, Gokulnath P, Lehmann HI, Hou Z, Yang S, You L, Zhang G, Xing Y, Lei J, Li G, Guo S, Shang H (2022). RNA modifications in aging-associated cardiovascular diseases. [Review]. Aging (Albany NY), 14(19), 8110-8136. (Read full article)
    4. Lehmann HI, Tsao L, Singh JP (2022). Treatment of cardiac resynchronization therapy non-responders: current approaches and new frontiers. [Review]. Expert Rev Med Devices, 19(7), 539-547. (Read full article)
    5. Jiapaer Z, Su D, Hua L, Lehmann HI, Gokulnath P, Vulugundam G, Song S, Zhang L, Gong Y, Li G (2022). Regulation and roles of RNA modifications in aging-related diseases. [Review]. Aging Cell, 21(7), e13657. (Read full article)

    Editorial

    1. Chen R, Lehmann HI, Xiao J (2022). Novel Effector Molecules Regulating Smooth Muscle Cell Contractility in Marfan Syndrome: Phosphoprotein 1 Secreted by Fibroblasts. J Cardiovasc Transl Res, 15(5), 957-958. (Read full article)

    Letter

    1. Gokulnath P, Spanos M, Lehmann HI, Sheng Q, Rodosthenous R, Chaffin M, Varrias D, Chatterjee E, Hutchins E, Li G, Daaboul G, Rana F, Wang AM, Van Keuren-Jensen K, Ellinor PT, Shah R, Das S (2024). Distinct Plasma Extracellular Vesicle Transcriptomes in Acute Decompensated Heart Failure Subtypes: A Liquid Biopsy Approach. [Letter to the editor]. Circulation, 149(14), 1147-1149. (Read full article)
    2. Lennon KM, Saftics A, Abuelreich S, Sahu P, Lehmann HI, Maddox AL, Bagabas R, Januzzi JL, Van Keuren-Jensen K, Shah R, Das S, Jovanovic-Talisman T (2022). Cardiac troponin T in extracellular vesicles as a novel biomarker in human cardiovascular disease. [Letter to the editor]. Clin Transl Med, 12(8), e979. (Read full article)